Transdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease

scientific article published in November 2005

Transdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0210-4806(05)73376-3
P8608Fatcat IDrelease_kaq7mgeshbesfgwype6dye446q
P698PubMed publication ID16447593

P50authorRamiro Cabello BenaventeQ73583890
P2093author name stringC Hernández Fernández
J I Monzó
I Moncada Iribarren
A de Palacio España
A Hernández Villaverde
P2860cites workLow-dose radiotherapy in 179 patients with Peyronie's disease: treatment outcome and current sexual functioningQ33180674
Peyronie's disease: a reviewQ35082687
A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.Q39383271
Tunica albuginea tissue analysis after electromotive drug administrationQ44398116
Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's diseaseQ44461634
Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind studyQ46329766
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.Q50951063
Topical beta-aminopropionitrile in the treatment of Peyronie's diseaseQ71712117
Autophotography in evaluation of functional penile disordersQ71779875
Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imagingQ73957484
P433issue10
P921main subjectverapamilQ410291
dexamethasoneQ422252
P304page(s)955-960
P577publication date2005-11-01
P1433published inActas Urológicas EspañolasQ15746072
P1476titleTransdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease
P478volume29

Reverse relations

Q37853180Current status and new developments in Peyronie's disease: medical, minimally invasive and surgical treatment optionscites workP2860

Search more.